Brokerages expect MedEquities Realty Trust Inc. (NYSE:MRT) to announce earnings per share of $0.30 for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for MedEquities Realty Trust’s earnings, with the highest EPS estimate coming in at $0.31 and the lowest estimate coming in at $0.29. MedEquities Realty Trust reported earnings of ($0.06) per share in the same quarter last year, which would suggest a positive year over year growth rate of 600%. The company is scheduled to issue its next earnings report on Monday, February 26th.
On average, analysts expect that MedEquities Realty Trust will report full-year earnings of $1.11 per share for the current fiscal year, with EPS estimates ranging from $1.09 to $1.12. For the next fiscal year, analysts anticipate that the business will post earnings of $1.22 per share, with EPS estimates ranging from $1.17 to $1.26. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that that provide coverage for MedEquities Realty Trust.
MRT has been the topic of several research reports. KeyCorp reissued a “buy” rating and set a $13.00 price target on shares of MedEquities Realty Trust in a research note on Friday, August 25th. Capital One Financial Corporation initiated coverage on shares of MedEquities Realty Trust in a research note on Monday, October 23rd. They set an “equal weight” rating and a $13.00 price target on the stock. B. Riley reissued a “buy” rating on shares of MedEquities Realty Trust in a research note on Wednesday, November 8th. Cantor Fitzgerald initiated coverage on shares of MedEquities Realty Trust in a research note on Thursday, August 31st. They set an “overweight” rating and a $14.00 price target on the stock. Finally, Zacks Investment Research raised shares of MedEquities Realty Trust from a “sell” rating to a “hold” rating in a research note on Wednesday, July 19th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the stock. MedEquities Realty Trust presently has a consensus rating of “Hold” and a consensus price target of C$13.00.
Shares of MedEquities Realty Trust (MRT) traded down C$0.21 during trading on Monday, reaching C$10.81. 217,500 shares of the company’s stock traded hands, compared to its average volume of 148,017. MedEquities Realty Trust has a twelve month low of C$10.06 and a twelve month high of C$13.06. The company has a market capitalization of $343.28, a price-to-earnings ratio of 9.83 and a beta of -0.70.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 29th. Stockholders of record on Wednesday, November 15th will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 7.77%. The ex-dividend date is Tuesday, November 14th. MedEquities Realty Trust’s dividend payout ratio (DPR) is presently 210.01%.
Several hedge funds have recently made changes to their positions in the company. Prudential Financial Inc. boosted its holdings in shares of MedEquities Realty Trust by 5.4% during the 3rd quarter. Prudential Financial Inc. now owns 2,658,837 shares of the company’s stock valued at $31,242,000 after buying an additional 136,499 shares in the last quarter. American Century Companies Inc. boosted its stake in MedEquities Realty Trust by 11.2% in the 3rd quarter. American Century Companies Inc. now owns 1,726,208 shares of the company’s stock worth $20,283,000 after purchasing an additional 174,261 shares in the last quarter. Boston Partners boosted its stake in MedEquities Realty Trust by 5.1% in the 3rd quarter. Boston Partners now owns 1,496,199 shares of the company’s stock worth $17,581,000 after purchasing an additional 72,270 shares in the last quarter. Vanguard Group Inc. boosted its stake in MedEquities Realty Trust by 5.9% in the 2nd quarter. Vanguard Group Inc. now owns 1,160,107 shares of the company’s stock worth $14,640,000 after purchasing an additional 64,766 shares in the last quarter. Finally, Eagle Boston Investment Management Inc. boosted its stake in MedEquities Realty Trust by 23.7% in the 2nd quarter. Eagle Boston Investment Management Inc. now owns 700,597 shares of the company’s stock worth $8,841,000 after purchasing an additional 134,095 shares in the last quarter. Hedge funds and other institutional investors own 94.13% of the company’s stock.
MedEquities Realty Trust Company Profile
MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.